A Perry Karsen

Affiliations

  • Director at Graphite Bio Inc. (GRPH), 2021-06-25
  • Director at Jounce Therapeutics Inc. (JNCE), 2021-06-22
  • Director at Intellia Therapeutics Inc. (NTLA), 2020-12-18
  • Director at Jiya Acquisition Corp. (JYAC), 2020-11-19
  • Director at Voyager Therapeutics Inc. (VYGR), 2019-06-17
  • Director at Oncomed Pharmaceuticals Inc (OMED), 2019-04-23
  • See Remarks at Celgene Corp (CELG), 2016-02-02
  • Director at Navidea Biopharmaceuticals Inc. (NAVB), 2015-07-21
  • Director at Agios Pharmaceuticals Inc (AGIO), 2015-06-25
  • Director at Alliqua Inc. (ALQA), 2013-12-05
  • President at Stalar 3 Inc. (NONE), 2011-01-24
  • President at Stalar 4 Inc. (NONE), 2011-01-21
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OMED $3.46 10,000 Director 10,000 2017-06-05 Filing
JNCE $16.00 5,000 Director 5,000 2017-02-01 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NTLA $54.33 21,336 Director 5,000 2020-12-17 Filing
NTLA $53.69 45,450 Director 26,336 2020-12-17 Filing
NTLA $52.52 21,978 Director 71,786 2020-12-17 Filing
CELG $115.00 47,173 Officer 62,820 2013-05-13 Filing
CELG $120.12 27,896 Officer 70,117 2015-02-11 Filing